Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome
Open Access
- 31 January 1996
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 97 (1) , 119-126
- https://doi.org/10.1016/s0091-6749(96)70290-7
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Evidence for Impaired Activation of the Hypothalamic-Pituitary-Adrenal Axis in Patients with Chronic Fatigue SyndromeJournal of Clinical Endocrinology & Metabolism, 1991
- Cytokine Levels in Serum and Cerebrospinal Fluid in Patients with Chronic Fatigue Syndrome and Control SubjectsThe Journal of Infectious Diseases, 1991
- Chronic fatigue syndrome: clinical condition associated with immune activationThe Lancet, 1991
- A Comprehensive Immunological Analysis in Chronic Fatigue SyndromeScandinavian Journal of Immunology, 1991
- Symptoms and Signs of Chronic Fatigue SyndromeClinical Infectious Diseases, 1991
- Immunological abnormalities in the chronic fatigue syndrome (for editorial comment, see page 117)The Medical Journal of Australia, 1989
- Allergy and the chronic fatigue syndromeJournal of Allergy and Clinical Immunology, 1988
- Chronic Fatigue Syndrome: A Working Case DefinitionAnnals of Internal Medicine, 1988
- Persisting Illness and Fatigue in Adults with Evidence of Epstein-Barr Virus InfectionAnnals of Internal Medicine, 1985
- PROLONGED ATYPICAL ILLNESS ASSOCIATED WITH SEROLOGICAL EVIDENCE OF PERSISTENT EPSTEIN-BARR VIRUS INFECTIONThe Lancet, 1982